If you choose Cologuard, you'll need a doctor to order ... Finally, you put everything back in the prepaid, pre-addressed box and ship it to a lab. At the lab, technicians look for not only ...

In the spot, a man makes his way up a stairway in his home. The stairway is lined with family photos and when he reaches the top landing, a woman hands him a Cologuard box and he enters a bathroom to ...

Medically reviewed by Steffini Stalos, DOFact checked by Nick BlackmerMedically reviewed by Steffini Stalos, DOFact checked ...

Exact Sciences rose Friday after the Food and Drug Administration approved its next-generation colon cancer detection test, ...

The blood is tested for biomarkers and DNA mutations that are present with cancer. Another option, Cologuard, can be done at home — you collect a sample of your stool and mail it to a lab with ...

Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the ...

The best mattress in a box is as high-quality as a bed you can find in a traditional brick-and-mortar store, but comes with the added bonus of delivering directly to your doorstep—no setup or ...

Fresh bread is one of life’s simple pleasures, and to make sure your bread doesn’t go stale before you’ve had a chance to finish it, every kitchen could benefit from a bread box. The best ...

Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...

The best lunch boxes make packing a midday meal — and cleaning up from it — easy and straightforward. They also need to be appealing and easy to use for the kids who’ll be toting them every ...

Puneet Souda’s rating is based on the expectation of broader adoption and higher volumes for Exact Sciences’s Cologuard Plus (CG+), which is anticipated to have higher specificity compared to ...

The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the firm's quarterly execution and forecast don't reflect its full potential.